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DObjective: The risk of acute type B aortic dissection is thought to increase with descending thoracic aortic di-
ameter. Currently, elective repair of the descending thoracic aorta is indicated for an aortic diameter of 5.5 cm or
greater. We sought to investigate the relationship between aortic diameter and acute type B aortic dissection, and
the utility of aortic diameter as a predictor of acute type B aortic dissection.
Methods:We examined the descending aortic diameter at presentation of 613 patients with acute type B aortic
dissection who were enrolled in the International Registry of Acute Aortic Dissection between 1996 and 2009,
and analyzed the subset of patients with acute type B aortic dissection with an aortic diameter less than 5.5 cm.
Results: The median aortic diameter at the level of acute type B aortic dissection was 4.1 cm (range 2.1–13.0
cm). Only 18.4% of patients with acute type B aortic dissection in the International Registry of Acute Aortic
Dissection had an aortic diameter of 5.5 cm or greater. Patients with Marfan syndrome represented 4.3% and
had a slightly larger aortic diameter than patients without Marfan syndrome (4.68 vs 4.32 cm, P ¼ .121). Com-
plicated acute type B aortic dissection was more common among patients with an aortic diameter of 5.5 cm or
greater (52.2% vs 35.6%, P<.001), and the in-hospital mortality for patients with an aortic diameter less than
5.5 cm and 5.5 cm or greater was 6.6% and 23.0% (P<.001), respectively.
Conclusions: The majority of patients with acute type B aortic dissection present with a descending aortic di-
ameter less than 5.5 cm before dissection and are not within the guidelines for elective descending thoracic aortic
repair. Aortic diameter measurements do not seem to be a useful parameter to prevent aortic dissection, and other
methods are needed to identify patients at risk for acute type B aortic dissection. (J Thorac Cardiovasc Surg
2011;142:e101-7)Acute type B aortic dissection (ABAD) is a serious cardio-
vascular condition that is associated with high mortality and
morbidity rates, and its incidence has increased over the last
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The Journal of Thoracic and Carthought to increase with increasing descending thoracic
aortic diameter.5-7 For thoracic aortic aneurysms with
a diameter larger than 6 cm, dissection occurs in
approximately 3.7% per year, and dissection, rupture, or
death occurs in approximately 15% per year.5-7 The risks
of elective thoracic aortic repair for preventing acute
dissection or rupture also are considerable, and the risks
of elective surgery have to be balanced against the risks
of the natural course of descending thoracic aortic
aneurysms. Establishing a diameter threshold value that
discriminates low from high risk of acute dissection is
therefore crucial. Although the optimal diameter threshold
is still under debate, current indications are to treat when
the descending thoracic aortic diameter is greater than 5.5
or 6.0 cm.5-9
However, on investigation of the descending thoracic aor-
tic diameter among patients with ABAD who were enrolled
in the International Registry of Acute Aortic Dissection
(IRAD), we observed that a substantial number of these pa-
tients do not seem to have markedly dilated aortic diame-
ters. We sought to assess the utility of aortic diameter as
a predictor of ABAD by investigating the subset of patients
with ABAD and an aortic diameter less than 5.5 cm whodiovascular Surgery c Volume 142, Number 3 e101
Abbreviations and Acronyms
ABAD ¼ acute type B aortic dissection
IRAD ¼ International Registry of Acute Aortic
Dissection
OR ¼ odds ratio
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Dwere enrolled in the IRAD, for whom elective descending
thoracic aortic repair would not be recommended.MATERIALS AND METHODS
Patient Selection
The inception and structure of the IRAD have been described
(Appendix 1).10 All patients presenting with ABAD who were enrolled
in the IRAD between 1996 and September 2009 were selected for analysis.
In total, we identified 613 patients with ABAD for whom data regarding the
aortic diameter were available. ABAD was defined as any dissection that
originated at the descending thoracic aorta in a patient who presented
within 14 days after onset of symptoms. Only patients in whom the de-
scending aortic diameter at presentation was available were included for
this evaluation; traumatic aortic dissections were excluded. Patients were
categorized according to aortic diameter less than 5.5 cm and 5.5 cm or
greater, and demographics, clinical presentation, management, and out-
comes of the 2 groups were compared.
Data Collection
Data were collected using standardized forms with more than 290 clinical
variables, including demographics, medical history, clinical presentation,
clinical findings, imaging studies, medical and surgical management, and
in-hospital outcomes. The maximum descending aortic diameters were mea-
suredbycomputed tomographyangiography, transesophageal echocardiogra-
phy, magnetic resonance imaging, or angiography at the time of presentation
with ABAD. If patients underwent multiple imaging studies, diameters from
the study that identified the largest aortic diameter were selected for analysis.
The maximum aortic diameter was measured at cross-sectional images per-
pendicular to the long axis of the descending aorta. In the IRAD, all aortic di-
ametermeasurementswere obtained after aorticdissectionhadoccurred.Data
were collected at presentation or by retrospective review and were submitted
to the IRAD coordinating center at the University of Michigan. Submitted
forms are checked for face validity and analytic internal validity.
Data Analysis
Data analysis was performed with the Statistical Package for the Social
Sciences (SPSS Inc, Chicago, Ill). The chi-square test was used for compar-
ing categoric variables between patients with an aortic diameter less than
5.5 cm and 5.5 cm or greater; the Student t test was used for comparing con-
tinuous variables between both groups. Summary statistics are presented as
frequencies and percentages for categoric variables and mean  standard
deviation for continuous variables. In all cases, missing data were not de-
faulted to negative, and denominators reflect only cases reported. Forward
stepwise logistic regression analysis was performed with variables that
reached P less than .20 on univariate analysis to investigate independent
predictors of in-hospital mortality at aortic diameter less than 5.5 cm.RESULTS
Aortic Diameters
The mean maximum diameter at the level of ABAD was
4.40  1.35 cm (range, 2.1–13.0 cm), and the median de-e102 The Journal of Thoracic and Cardiovascular Surscending thoracic aortic diameter was 4.1 cm (Figure 1).
Among all 613 patients with ABAD, 81.6% had an aortic
diameter less than 5.5 cm, which is the current threshold
for elective descending thoracic aortic repair (Figure 1),
and 40.3% had an aortic diameter less than 4.0 cm. Only
18.4% of patients with ABAD in the IRAD had an aortic di-
ameter of 5.5 cm or greater.
Demographics and Clinical History
Patients with an aortic diameter of 5.5 cm or greater were
more likely to have experienced a prior aortic dissection
(19.1% vs 7.7%, P< .001) or a known aortic aneurysm
(39.6% vs 16.8%, P<.001). Marfan syndrome was present
in 6.4% of patients with an aortic diameter 5.5 cm or greater
compared with 3.8% in patients with an aortic diameter less
than 5.5 cm (P¼ .227) (Table 1). The mean aortic diameter
in patients with Marfan syndrome was 4.68 cm versus 4.32
cm in patients without Marfan syndrome (P ¼ .121).
Presentation and Imaging Results
Patients with an aortic diameter less than 5.5 cm pre-
sented more frequently with hypertension (70.1% vs
47.3%, P< .001) and less frequently with normotension
(26.1% vs 45.5%, P < .001) or in hypovolemic shock
(0.6% vs 3.6%, P ¼ .008). Complicated ABAD, defined
as patients presenting with preoperative mesenteric ische-
mia/infarction or acute renal failure, limb ischemia, spinal
cord ischemia, shock, recurrent pain, refractory pain, or re-
fractory hypertension, were more common among patients
with an aortic diameter 5.5 cm or greater (52.2% vs 35.6%,
P< .001, Table 2). Periaortic hematoma was more fre-
quently diagnosed in this group (28.0% vs 13.7%,
P<.001).
As expected, patients with an aortic diameter less than
5.5 cm were more likely to have a normal chest x-ray
(29.1% vs 10.6%, P<.001), whereas a widened mediasti-
num, an abnormal aortic contour, displacement of the aorta,
and pleural effusion were more frequent on chest x-rays of
patients with an aortic diameter 5.5 cm or greater (Table 2).
Partial false lumen thrombosis was more common in pa-
tients with enlarged aortas (53.0% vs 33.0%, P<.001).
Mean aortic arch diameter was 3.61 cm (1.24) and sig-
nificantly larger in patients with an aortic diameter 5.5 cm
or greater (3.49 vs 4.16, P< .001). The site of origin of
the ABAD was more commonly at the level of the left sub-
clavian artery for those patients with an aortic diameter less
than 5.5 cm (58.7% vs 44.0%, P¼ .005), whereas for those
with an aortic diameter 5.5 cm or greater, the ABAD was
more likely to be in the descending aorta (20.9% vs
33.9%, P ¼ .002) (Table 2).
Management and Outcomes
Medical management was offered to 72.0% of patients
with an aortic diameter less than 5.5 cm compared withgery c September 2011
FIGURE 1. Descending aortic diameter in patients with ABAD in the IRAD. Among all 613 patients with ABAD, 81.6% had an aortic diameter less than
5.5 cm, which is the current threshold for elective descending thoracic aortic repair.
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(P¼ .009). Surgical management was used more frequently
in patients with an aortic diameter 5.5 cm or greater (39.6%
vs 20.6%, P<.001), whereas patients with an aortic diam-
eter less than 5.5 cm were more likely to undergo endovas-
cular management (7.4% vs 0.9%, P ¼ .008).
Increasing diameter was associated with increasing risk
of in-hospital mortality (Figure 2). Overall, the in-hospital
mortality was 6.6% for patients with an aortic diameter
less than 5.5 cm and 23.0% for patients with an aortic diam-
eter 5.5 cm or greater (P<.001). The mean aortic diameterTABLE 1. Demographics and clinical history
Overall
Descen
diamet
N (%) 613 (100) 500
Demographics
Age (SD) 63.9 (14.0) 62.9
Age  70 y 219 (36.6) 168
Male 409 (66.7) 335
History
Marfan syndrome 26 (4.3) 19
Bicuspid aortic valve 9 (1.9) 8
IMH 116 (19.1) 97
Hypertension 486 (79.8) 392
Atherosclerosis 207 (34.3) 166
Diabetes 42 (7.0) 31
Known aortic aneurysm 127 (21.0) 83
Prior aortic dissection 59 (9.8) 38
Prior aortic repair 84 (14.1) 63
Prior CABG 28 (4.8) 23
Prior catheterization/
angiography
42 (9.1) 37
Iatrogenic dissection 12 (2.1) 12
SD, Standard deviation; IMH, intramural hematoma; CABG, coronary artery bypass grafti
The Journal of Thoracic and Carof nonsurvivors was 5.22 cm, compared with 4.32 cm for
survivors (P<.001). Among patients managed medically,
the in-hospital mortality was 4.4% versus 25.4% for pa-
tients with an aortic diameter less than 5.5 cm and 5.5 cm
or greater, respectively (P<.001). The mortality did not dif-
fer significantly between groups after surgical or endovas-
cular management (Table 3).
Independent predictors for mortality among patients with
an aortic diameter less than 5.5 cm were hypotension or
shock (odds ratio [OR], 8.6; P ¼ .001), acute renal failure
(OR, 3.6; P ¼ .014), mesenteric ischemia/infarction (OR,ding aortic
er<5.5 cm
Descending aortic diameter
 5.5 cm P value
(81.6) 113 (18.4)
(13.5) 65.2 (14.1) .111
(34.3) 51 (47.2) .012
(67.0) 74 (65.5) .758
(3.8) 7 (6.4) .227
(2.0) 1 (1.3) .997
(19.5) 19 (17.1) .561
(78.7) 94 (84.7) .157
(33.5) 41 (38.0) .380
(6.3) 11 (10.2) .154
(16.8) 44 (39.6) <.001
(7.7) 21 (19.1) <.001
(13.0) 21 (19.3) .089
(4.8) 5 (4.6) .943
(9.6) 5 (6.5) .392
(2.5) 0 (0) .136
ng.
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TABLE 2. Presenting symptoms and imaging findings
N (%) Overall
Descending aortic
diameter<5.5 cm
Descending aortic diameter
 5.5 cm P value
Presenting hemodynamics
Hypertensive 396 (65.9) 344 (70.1) 52 (47.3) <.001
Normotensive 178 (29.6) 128 (26.1) 50 (45.5) <.001
Hypotensive 20 (3.3) 16 (3.3) 4 (3.6) .842
Shock 7 (1.2) 3 (0.6) 4 (3.6) .008
Complicated 237 (38.7) 178 (35.6) 59 (52.2) .001
Chest x-ray findings
Normal 140 (25.5) 129 (29.1) 11 (10.6) <.001
Widened mediastinum 249 (46.2) 190 (43.5) 59 (57.8) .009
Abnormal aortic contour 244 (46.2) 187 (43.8) 57 (56.4) .022
Displacement/calcification
of aorta
47 (9.1) 30 (7.2) 17 (17.2) .002
Pleural effusion 84 (16.1) 61 (14.5) 23 (23.0) .037
Additional imaging findings
Periaortic hematoma 90 (16.3) 62 (13.7) 28 (28.0) <.001
Patent false lumen 230 (47.9) 199 (50.1) 31 (37.3) .034
Partial false lumen
thrombosis
175 (36.5) 131 (33.0) 44 (53.0) .001
Complete thrombosis 75 (15.6) 67 (16.9) 8 (9.6) .099
Mean descending aorta
diameter
4.40 (1.35) 3.90 (0.74) 6.62 (1.22) <.001
Site origin LSA 335 (56.0) 287 (58.7) 48 (44.0) .005
Site origin descending aorta 135 (22.6) 98 (20.0) 37 (33.9) .002
Site origin abdominal 21 (3.5) 18 (3.7) 3 (2.8) .634
‘‘Complicated’’ includes those with mesenteric ischemia, acute renal failure, limb ischemia, spinal cord ischemia, shock, periaortic hematoma, recurrent pain, refractory pain, or
refractory hypertension. LSA, Left subclavian artery.
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P ¼ .019) (Table 4).
DISCUSSION
The risks of aortic dissection or rupture are thought to in-
crease with increasing aortic diameter, and for thoracic aor-
tic aneurysms larger than 6 cm, the annual risk of aortic
dissection, rupture, or death is approximately 15%.5-7 The
natural history analysis by Elefteriades5 revealed a sharp
hinge point of risk for descending thoracic aortas 7 cm or
greater, where aortic dissection or rupture becomes more
likely. Current guidelines therefore recommend elective de-
scending thoracic aortic intervention in cases of an aorticTABLE 3. In-hospital management and outcomes
N (%) Overall
Descending a
diameter<5
Definitive management
Medical 426 (69.7) 360 (72.0
Surgery 147 (24.1) 103 (20.6
Endovascular 38 (6.2) 37 (7.4)
In-hospital mortality 53 (9.6) 30 (6.6)
Medical 29 (7.7) 14 (4.4)
Surgery 20 (14.5) 12 (12.2
Endovascular 4 (11.1) 4 (11.4
e104 The Journal of Thoracic and Cardiovascular Surdiameter larger than 5.5 or 6.0 cm in an effort to prevent
life-threatening complications.5-9
Our IRAD data show that more than 80% of patients with
ABAD in the IRAD had an aortic diameter less than 5.5 cm
at presentation. On this basis, elective surgery would not
have been indicated to prevent aortic B dissection according
to current guidelines. Elefteriades5 showed that the annual
incidence of thoracic aortic rupture gradually increased
from 0% to 3.6% in patients with aortic diameters of 3.5
cm and 6.0 cm, respectively, whereas the incidence of aortic
dissection only increased from 2.2% to 3.7% for patients
with similar aortic measurements. Therefore, the relation-
ship between increasing aortic diameter and risk of aorticortic
.5 cm
Descending aortic diameter
 5.5 cm P value
) 66 (59.5) .009
) 44 (39.6) <.001
1 (0.9) .008
23 (23.0) <.001
15 (25.4) <.001
) 8 (20.0) .240
) 0 (0) .732
gery c September 2011
FIGURE 2. In-hospital mortality related to the descending aortic diameter. The in-hospital mortality was 6.6% for patients with an aortic diameter less than
5.5 cm and 23.0% for patients with an aortic diameter 5.5 cm or greater (P<.001).
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Drupture is far more linear than that for aortic dissection. This
calls to mind the notion that fundamentally, rupture and dis-
section presumably have different triggers, and current sci-
ence is inadequate for risk assessment and prevention. The
median diameter of ABAD in the IRAD cohort was 4.1 cm,
and it was surely even smaller when the acute event oc-
curred, because the aortic measurements reported in the reg-
istry were obtained after acute dissection. These aortic
diameters are also considerably smaller than those reported
for ruptured descending thoracic aortas, which usually
range from 6 to 8 cm.5-8,11-13
AlthoughABAD seems to occur at a considerably smaller
size than the current threshold for elective descending tho-
racic aortic repair, lowering the cutoff for aortic intervention
is certainly not the solution for this problem. It is likely that
many affected individuals in the world have a descending
aorta larger than 4 cm in diameter. Yet, we believe that
only a small fraction will ultimately dissect. The medical,
emotional, and financial risk of intervening on this popula-
tion would be substantial and unpredictable. Before eventu-
ally genetic, proteomic, or imaging profiles help to identify
patients at high risk, a conservative approach is justified.TABLE 4. Independent predictors of death in patients with aortic
diameter less than 5.5 cm
Variable Odds ratio 95% CI P value
Hypotension/shock 8.60 2.30–32.04 .001
Acute renal failure 3.56 1.28–9.87 .014
Mesenteric ischemia 5.42 1.45–20.28 .012
Peri-aortic hematoma 3.40 1.22–9.49 .019
CI, Confidence interval.
The Journal of Thoracic and CarPredicting ABAD seems to bemore difficult than predict-
ing descending thoracic aortic rupture, and other risk factors
than increasing aortic diameter may play an important role
in the development of ABAD. Identification of patients with
aortic diameters less than 5.5 cm who are at risk for devel-
oping acute aortic events remains essential. Patients with
ABAD with an aortic diameter less than 5.5 cm presented
more frequently with hypertension, whereas the overall
prevalence of preexisting hypertension before dissection
was similar in both groups (<5.5 cm and 5.5 cm). In
this context, poor blood pressure control may play a role
in the cause of ABAD in patients with an aortic diameter
less than 5.5 cm.
In patients with Marfan syndrome, the risk of aortic dis-
section and rupture, particularly of the aortic root, is in-
creased,5,6,14 and the thresholds for prophylactic aortic
replacement are typically lower for this specific patient
group.5,6,14-17 In the IRAD ABAD cohort, the incidence
of Marfan syndrome was not increased among patients
with an aortic diameter less than 5.5 cm, but the mean
aortic diameter tended to be even slightly larger in
patients with Marfan syndrome than in others (4.68 vs
4.32 cm). Although type B aortic dissection did not
develop in patients with Marfan syndrome and smaller
aortic diameters than patients without Marfan syndrome
in the IRAD, conclusions are difficult to draw with
a limited sample size.
It remains unclear whether the patients in whom type B
aortic dissections develop in aortas less than 5.5 cm are dif-
ferent from others. The IRAD cannot be used to investigate
which patients are at risk of developing ABAD because of
the observational nature of this registry and the absencediovascular Surgery c Volume 142, Number 3 e105
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tissue disorders are known to affect the integrity of the arte-
rial wall, resulting in increased risks of aortic dissection, an-
eurysm formation, and rupture, such as Marfan syndrome,
Ehlers–Danlos syndrome type IV, Turner’s syndrome, and
other less well-known connective tissue disorders that
have been associated with aortic dissection.18-21 Recent
research has focused on the genetic and proteomic
background of thoracic aortic disease, and it seems that
up to 20% of patients with thoracic aortic aneurysms or
dissections have a family history of thoracic aortic disease
without being affected by any syndrome.5,22,23 Research
projects on aortic diseases, such as the National Registry
of Genetically Triggered Thoracic Aortic Aneurysms and
Cardiovascular Conditions, have been established to
further investigate genetically triggered thoracic aortic
disease and the optimal clinical management of these
patients.24 Such initiatives may improve the current knowl-
edge on individualized treatment of the descending thoracic
aorta with a diameter less than 5.5 cm, who are at high risk
for ABAD and require prophylactic thoracic aortic medical
treatment or intervention to prevent its development.
Although ABADs developed in aortas less than 5.5 cm in
the majority of patients in the IRAD, complicated ABAD
was more common among patients with an aortic diameter
5.5 cm or greater. In particular, periaortic hematoma, sug-
gesting ‘‘contained’’ aortic rupture, was more common
among these patients, who subsequently underwent surgery.
The increased incidence of complicated ABAD among pa-
tients with an aortic diameter greater than 5.5 cm paralleled
with increased mortality in this group.
The present study has several strengths and limitations.
The IRAD database contains the largest series of patients
with ABAD to date, which provided a unique opportunity
to investigate the relationship between aortic diameter and
ABAD. Aortic size measurements were obtained after
acute dissection and thus would tend to overestimate
size, which further supports the inaccuracy of aortic diam-
eter as a predictor of ABAD. Unfortunately, the IRAD
does not have a disease-free control group, and therefore
the data cannot be used to investigate which patients are
at risk of developing ABAD. Furthermore, data regarding
blood pressure control before the event, which may play
an important role in the cause of dissection, were unavail-
able in IRAD.
CONCLUSIONS
The majority of patients with ABAD present with a de-
scending aortic diameter less than 5.5 cm and miss the
threshold for elective descending thoracic aortic repair.
The findings of the present study suggest that descending
aortic diameter is not a useful parameter to predict acute
type B dissection. To prevent ABAD, further natural history
studies are needed, as well as research on genetic predispo-e106 The Journal of Thoracic and Cardiovascular Sursition for thoracic aortic disease. These may reveal other
risk factors for aortic dissection in addition to increasing
aortic diameter, resulting in better medical and interven-
tional criteria for prophylactic thoracic aortic repair.References
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